Earnings Special: Nvidia Forecast Fails to Impress (Podcast)

Nvidia guided current-period sales to $108B (+/-2%), above the $105.2B average but short of some higher Street expectations (> $110B), signaling uneven AI-spend momentum. The company also projected gross margin of roughly 74%. Despite the beat vs consensus, the forecast disappointment is likely to keep investor sentiment cautious into the next quarter.

Analysis

This is less about an outright demand miss and more about a crowded positioning reset. NVDA is priced like a call option on accelerating AI capex, so even a guide that is still robust can underwhelm if it doesn’t clear the market’s whisper number by enough to justify the premium multiple. The immediate risk is multiple compression first, fundamentals second; in that setup, the stock can trade down on sentiment even if the underlying revenue trajectory remains strong.

The second-order winners are not necessarily direct chip peers but the broader AI spend chain: hyperscalers, networking, and software names benefit if budgets stay intact while investors rotate away from the single-name beta. The key tell over the next 1-3 months is whether MSFT, AMZN, META, and GOOGL reaffirm elevated capex; if they do, this looks like a stock-specific de-rating, not an AI-cycle top. If those budgets soften, then the downside broadens quickly into SOXX/SMH and the whole AI complex.

Contrarian takeaway: the consensus may be overreacting to a guide that is still far above pre-AI-cycle norms. What the market is really testing is whether the growth rate can keep re-accelerating from already huge levels; if not, the valuation has to do more of the work. The bear case is falsified if the next hyperscaler prints confirm continued spend discipline and NVDA holds its post-earnings gap into the next 2-4 weeks.

Key Decisions for Investors

• Tactically fade any post-earnings relief rally in NVDA over the next 1-2 weeks via a call spread or small outright short; the edge is in multiple compression, not a structural revenue break. Cover if NVDA reclaims the post-print high and SOXX stops underperforming.
• Pair trade: short NVDA / long AVGO for 1-3 months to express 'AI spend persists, but concentration premium narrows.' AVGO offers broader monetization and less single-product dependency; risk is that a true AI capex rollover hits both legs.
• For portfolio construction, rotate a portion of AI beta from NVDA into diversified beneficiaries such as MSFT or AMZN on weakness; this keeps exposure to capex while reducing single-name valuation risk. Falsify if those names cut 2026 capex commentary.
• Set a hard alert on the next hyperscaler earnings cycle: any downward revision to AI infrastructure spend should trigger a broader de-risking of SOXX/SMH and adjacent hardware names.
• No aggressive long in NVDA until the market sees at least one more data point on Blackwell ramp and order durability; absent that, risk/reward favors staying underweight rather than buying the dip.